Dr. Sanford R. Dolgin, MD

Dr. Dolgin practices at ENT and Allergy Associates of Florida in Brooksville, Florida.

Dr. Dolgin's NPI, 1962494815, was assigned on August 17, 2005. Dr. Dolgin graduated from University of Miami, Miller School of Medicine in 1985. Dr. Dolgin holds Florida license ME0060810.

Dr. Dolgin's primary practice is ENT and Allergy Associates of Florida, at 11373 Cortez Blvd, Brooksville, FL 34613 in Hernando County. The practice phone is (561) 338-3267.

Dr. Dolgin's primary practice is ENT and Allergy Associates of Florida in Brooksville, Florida. Dr. Dolgin is also affiliated with HCA Florida Oak Hill Hospital. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Dolgin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dolgin practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Dolgin's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Dolgin is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Dolgin's licenses on file in 3 states: Florida, Georgia and Ohio.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Dolgin treats.

CMS data shows 1,109 Medicare services from Dr. Dolgin across 12 procedure codes in 2024, for 463 Medicare patients. Medicare paid $70,471 for them. Every service was in an office.

CMS counts 463 Medicare patients who saw Dr. Dolgin in 2024. The largest group is 75 to 84, with 197 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dolgin's median patient age at 72, with 53% women.

In 2024, Dr. Dolgin wrote 954 Medicare Part D claims for 308 patients. 97% of them were for generic drugs. CMS names the drug for 851 of them, across 18 drugs with 11 or more claims each, at $92,953 in total drug cost. In 2023, CMS named 777 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dolgin for performance year 2024, reported individually. Dr. Dolgin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Dolgin. Dr. Dolgin's most frequent co-author is Stephen Dolgin, MD.

CMS Open Payments shows 47 general payments to Dr. Dolgin from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Covidien LP paid the most, $525. It also lists 1 research payment totaling $600 in 2017.

Dmand AI lists 4 awards for Dr. Dolgin, most recently CMS Stage 1 EHR in 2013.

Dr. Dolgin graduated from University of Miami, Miller School of Medicine in 1985. Dr. Dolgin is a member of NHS.

Dr. Dolgin is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.